LungBlog

Patients suffering from “unfashionable” cancers are being neglected by scientists in spite of record spending on cancer research, according to a new report by the National Cancer Research Institute (NCRI).

 

Some of the deadliest cancers, such as those affecting the lung and pancreas, get the least amount of public money, while five cancers with some of the best survival rates, including breast and leukaemia, receive nearly two-thirds of the money.